• Subscribe
  • Log In
  • Home
  • Daily Diary
  • Asset Class
    • U.S. Equity
    • Fixed Income
    • Global Equity
    • Commodities
    • Currencies
  • Sector
    • Basic Materials
    • Consumer Discretionary
    • Consumer Staples
    • Energy
    • Financial Services
    • Healthcare
    • Industrials
    • Real Estate
    • Technology
    • Telecom Services
    • Transportation
    • Utilities
  • Latest
    • Articles
    • Video
    • Columnist Conversations
    • Best Ideas
    • Stock of the Day
  • Street Notes
  • Authors
    • Bruce Kamich
    • Doug Kass
    • Jim "Rev Shark" DePorre
    • Helene Meisler
    • Jonathan Heller
    • - See All -
  • Options
  • RMPIA
  • Switch Product
    • Action Alerts PLUS
    • Quant Ratings
    • Real Money
    • Real Money Pro
    • Retirement
    • Stocks Under $10
    • TheStreet
    • Top Stocks
    • Trifecta Stocks
  1. Home
  2. / Investing
  3. / Energy

A Portfolio of Fixed Income, Pass Throughs and Small Caps

This portfolio is designed to produce a blended yield of 6% to 8%.
By JIM COLLINS
Apr 20, 2017 | 03:00 PM EDT
Stocks quotes in this article: CPE-A, NAP, ARR, CMO, NEWT, NM, TRCH, GST, EPM, GEMP, ICAD

The most challenging -- and fun -- part of my job as an investment advisor is constructing a new portfolio. As I use a "fee-only" model, I never put my clients in funds or ETFs that have embedded expense ratios and up-front sales loads. No, I pick individual securities, and I am fortunate enough to be starting with new clients this week. So, the question anyone in finance is asked at cocktail parties "what are you buying" becomes the more time-sensitive "what are you buying NOW?" Building portfolios is not an easy task, especially since I try to keep my clients fully invested at all times.

So, what am I buying NOW? It's a mix of the securities I have written about for Real Money over the past few months, plus a few new ideas. Philosophically, the asset allocation is still the same: heavy on corporate fixed-income securities, mezzanine securities (preferred) pass-through securities (BDC-RICs, REITs) and a common stock component that is entirely composed of small-capitalization stocks.

It may look like a dog's breakfast, but actually this type of portfolio will produce steady returns in a flat-to-down market. I have no idea when the Trump Jump will end, but I know that equity valuations are currently at cycle-highs, and I need to beat that market. With a blended yield in the 6%-8% range, my portfolios have guaranteed returns that the S&P 500 -- current yield 1.94% -- sorely lacks.

So, in each of those buckets, here are some individual names I plan to buy this week and next.

Corporate Fixed Income:

As with stocks, I feel that energy offers the most return among fixed-income securities. My favorite name in the space remains Callon Petroleum's 10% Series A prefs (CPE-A)  These prefs, astoundingly, still yield 9.46%. The oil bust has already happened. These are not risky securities and although there is call risk (first call date is 5/30/2018) there is no reason CPE-A should be yielding more than 4x the benchmark 10-year Treasury.

Pass-Throughs:

My favorite here remains Navios Maritime Midstream Partners (NAP) . NAP is a master limited partnership registered as C-Corp. and its 14.1% current yield more than adequately reflects the risk inherent in its fleet of 6 VLCC oil tankers. I also like the mortgage REITs (ARMOUR Residential REIT (ARR) ,Capstead Mort RE Rg (CMO) ) and certain BDC-RICs here, especially Newtek (NEWT)

Small stocks:

These are covered in my newsletter, MicroCap Guru. The biggest winner so far has been Navios Maritime (NM) . The preferreds put me easily on top of the Real Money Best Ideas list, but, today, I see much more upside in the common. It's nearly doubled since I featured it in MCG Issue 1 in August, but I'm still buying more.

ln a recent RM column I recommended purchase of three small energy names -- Evolution Petroleum (EPM) , Gastar Exploration (GST) and Torchlight Energy (TRCH)  -- and I'm still buying all three at current prices.

Also, though I am certainly not an expert, I try to keep some exposure to medtech and biopharma. Gemphire Therapeutics (GEMP)  has been a strong performer since I mentioned it in the MCG and in Real Money, but I think that one has a long way to run with recently raised capital being directed toward clinical trials.

A new name I have been adding is iCAD (ICAD) . The shares are still trading at less than half of their mid-2015 value and 2016 financial results showed a company in transition. I believe we are near the most lucrative of investing events for iCAD, the inflection point. I look for revenue growth to begin anew as we move through 2017 and for positive results for the stock from upcoming industry presentations and new data releases. I had a very smart PM with a background at a very large Boston-based fund manager describe iCAD to me as the "next Intuitive Surgical" and if ICAD performs anywhere near as well as ISRG has, it will truly be a winner for my clients and me.

Get an email alert each time I write an article for Real Money. Click the "+Follow" next to my byline to this article.

At the time of publication, Collins's firm was long GEMP, ICAD, NM, NAP, NM-G, NM-H, EPM, GST, ARR, NEWT and TRCH.

TAGS: Investing | U.S. Equity | Healthcare | Energy | Fixed income | Earnings | Funds | Stocks | Dividends | MLPs | Preferred Stocks

More from Energy

Oil, War and Inflation: Here's Where Prices Are Likely Headed

Carley Garner
May 18, 2022 1:00 PM EDT

Oil has a war and inflation hedge premium, but those aren't permanent.

Occidental Petroleum Continues to Target Higher Prices

Bruce Kamich
May 16, 2022 2:52 PM EDT

Here's our first price target and our long term objective.

Diamondback's FANGs Could Dull in the Short-Term

Bruce Kamich
May 13, 2022 9:30 AM EDT

Let's check out the charts of this oil producer.

Trading for a Bounce -- Not a Bottom

Peter Tchir
May 10, 2022 10:00 AM EDT

Here's my thinking on the Nasdaq, bonds, energy, commodities and crypto right now.

If You Insist on Trading This Brutal Market, Don't Get Lazy With Your Stops

Bob Byrne
May 10, 2022 8:30 AM EDT

That word of warning applies to ETFs and individual stocks such as Intercept Pharmaceuticals, which we outline a trading strategy for here.

Real Money's message boards are strictly for the open exchange of investment ideas among registered users. Any discussions or subjects off that topic or that do not promote this goal will be removed at the discretion of the site's moderators. Abusive, insensitive or threatening comments will not be tolerated and will be deleted. Thank you for your cooperation. If you have questions, please contact us here.

Email

CANCEL
SUBMIT

Email sent

Thank you, your email to has been sent successfully.

DONE

Oops!

We're sorry. There was a problem trying to send your email to .
Please contact customer support to let us know.

DONE

Please Join or Log In to Email Our Authors.

Email Real Money's Wall Street Pros for further analysis and insight

Already a Subscriber? Login

Columnist Conversation

  • 01:44 PM EDT STEPHEN GUILFOYLE

    Stocks Under $10 Portfolio

    We're making a series of trades here.
  • 03:07 PM EDT PAUL PRICE

    Why Is Walmart Down Big Today?

    Besides its poor earnings report Walmart was way...
  • 07:14 PM EDT PAUL PRICE

    A New, Very Scary Movie

  • See More

COLUMNIST TWEETS

  • A Twitter List by realmoney
About Privacy Terms of Use

© 1996-2022 TheStreet, Inc., 225 Liberty Street, 27th Floor, New York, NY 10281

Need Help? Contact Customer Service

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data & Company fundamental data provided by FactSet. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by FactSet Digital Solutions Group.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

FactSet calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.

Compare Brokers

Please Join or Log In to manage and receive alerts.

Follow Real Money's Wall Street Pros to receive real-time investing alerts

Already a Subscriber? Login